VSH · Vishay Intertechnology, Inc. · Stock research

ം# VSH Vishay Intertechnology, Inc.

Current Thesis

The cyclical re-rate is unwinding faster than it was built. Vishay's Q1 2026 print (2026-05-13) was genuine $839.2M revenue against ~$822.8M consensus, book-to-bill 1.34, $1.6B backlog at 5.7 months of coverage and the stock ran to $69.47 on it. Management then sold 15M shares at $50 on 2026-06-30 to raise $750M. Every buyer of that placement is underwater roughly 24% nineteen days later: the stock printed $35.67 intraday on 2026-07-16 and closed 2026-07-17 at $37.81, down 36.4% over one month and 45.6% from the high. Three covering analysts average a $34 target, below spot. The distribution phase of a passives up-cycle re-rate looks like this an issuer monetizing the multiple at the top, then a tape that cannot hold the placement price. What remains is a components cyclical trading at 35x forward earnings into an 2026-08-05 print, with the entire technical structure of the advance already surrendered.

Bullish and bearish views on Vishay Intertechnology, Inc.

The model's bull view on Vishay Intertechnology, Inc. (VSH), in brief: Q1 2026 (2026-05-13): revenue $839.2M vs ~$822.8M consensus, EPS $0.05 vs $0.03; book-to-bill of 1.34 with a $1.6B backlog covering 5.7 months is order strength a single restock quarter does not manufacture. The bear view: Price has round-tripped the re-rate. Down 36.4% in a month, 45.6% off $69.47, and now below the $50 placement the sequence of 2026-07-07 (-8.6% to $42.19), 2026-07-13 (-6.1% to $41.94) and 2026-07-16 (-7.4% to $37.46) is orderly supply, not a single shock. The dilution is the… Both cases follow in full.

Bull Case

• Q1 2026 (2026-05-13): revenue $839.2M vs ~$822.8M consensus, EPS $0.05 vs $0.03; book-to-bill of 1.34 with a $1.6B backlog covering 5.7 months is order strength a single restock quarter does not manufacture.
• Q2 guide issued 2026-05-13 at $875M–$905M sits above the ~$858M Street mark; the $890M midpoint implies ~6% sequential growth off $839M.
• Demand breadth cited on the Q1 call spans automotive, industrial, aerospace-defense and AI-adjacent power applications, with distribution-channel sell-through leading a recovery widening rather than concentrating.
• The $750M raise (2026-06-30) is earmarked for growth capex and debt reduction; Vishay qualified two additional subcontractors in Q1 for rectifiers and aluminum capacitors, adding supply against the backlog rather than rationing it.
• Defense-adjacent qualification progressed with CMMC Level 2 certification for secure support of U.S. defense programs, supporting the aerospace-defense content mix.
• Positioning is already bearish: one sell rating outstanding, a $34 average target beneath the market, and BofA's Underperform at $28 (raised from $18, 2026-05-14). A Q2 beat on 2026-08-05 would land against consensus that has stopped expecting one.

Bear Case

• Price has round-tripped the re-rate. Down 36.4% in a month, 45.6% off $69.47, and now below the $50 placement the sequence of 2026-07-07 (-8.6% to $42.19), 2026-07-13 (-6.1% to $41.94) and 2026-07-16 (-7.4% to $37.46) is orderly supply, not a single shock.
• The dilution is the tell on management's own view of value: selling ~10% of the company at $50 while the tape was $56 says the insider read on the multiple was below the print.
• Margin has not followed volume. Q2 gross-margin guidance of ~22.0% sits far under the 30%+ historical band, and the 2028 margin path carries elevated materials cost and tariff exposure.
• Valuation still has room to compress. Forward P/E of 35.5x on a $5.80B market cap, against 2025 revenue of $3.07B (+4.5%) and a net loss of $8.98M, is a growth multiple on a components cyclical.
• Macro turned against the theme: a report of SK Hynix slowing AI-memory capacity expansion cut the data-center power narrative, and hawkish Fed repricing under Chair Warsh pushed market-implied odds of a second 2026 hike to ~85% from ~60% a direct hit to industrial capex multiples.
• Freshly placed shares from the 2026-06-30 offering sit as overhang on any recovery toward $50.

Setup & Price Structure

Structure is broken on every timeframe that matters. The $44 shelf that held the post-Q1 breakout base gave way in the first half of July; the rising 20-week trend that carried price from $11.77 is gone. The 2026-07-16 low of $35.67 is the current line in the sand, and the +3.8% bounce to $37.81 on 2026-07-17 is a one-day reaction inside a downtrend, not a base. There is no higher low to reference and no volume shelf between roughly $36 and the pre-Q1 congestion in the high $20s. A name that fell 36% in a month does not offer a low-risk entry until it builds two to three weeks of sideways range with contracting volatility no such range exists yet. Buying into this decline on the argument that the Q1 order book was real is exactly the averaging-into-weakness pattern that turns a cyclical trade into a position; the order book was real in May and the stock is 46% lower.

Catalyst Calendar (next 30 days)

• 2026-08-05 (confirmed) Q2 2026 results for the quarter ended 2026-07-04, released before the NYSE open, conference call 09:00 ET. The binary: whether book-to-bill holds above 1.0, whether revenue landed inside the $875M–$905M guide, and whether gross margin cleared the ~22.0% guide.
• 2026-07-29 through 2026-08-04 the three-session window ahead of the print. No fresh entries belong here; the risk is binary and the tape is already in distribution.
• Late July / early August (est.) peer prints across analog and discrete components set the read-through on auto and industrial order rates. A peer cutting the second-half auto guide would remove the last support under the cycle-turn argument before Vishay speaks.

What Would Change Our Mind

A weekly close back above $44 would reclaim the surrendered breakout shelf and argue the July decline was a dilution-driven flush rather than a cycle-top. Reclaiming $50 the placement price with expanding volume would put the offering buyers whole and remove the overhang. On fundamentals, an 2026-08-05 print with book-to-bill above 1.2, revenue at or above the $905M guide top, and gross margin stepping toward 25% would restore the volume-and-margin recovery that the equity was paying for. Analyst revisions are the confirming signal: upgrades from a $34 average target, or BofA abandoning its $28 Underperform, would mean sell-side is finally chasing the fundamentals instead of the tape. Absent those, the name is a component cyclical in drawdown with a rich forward multiple and no technical structure.

Correlation Notes

Vishay trades as high-beta SOXX with a lag it moves on the analog and discrete complex (TXN, ON, MCHP, ADI) rather than on compute or memory. There is no HBM, GPU or datacenter-logic exposure; the AI link runs only through power-component content in capacitor banks, MOSFETs and optocouplers into data-center, grid and EV builds, which is second-order and small. That distinction matters when AI headlines move the sector: the SK Hynix capacity report hit VSH through sentiment, not through revenue. The name is more genuinely correlated to auto production schedules, industrial capex and distribution-channel inventory than to anything in the AI stack, which makes rate repricing under the current Fed a heavier input than any semiconductor headline. Correlation to the $750M placement's holders is the near-term technical driver until that supply clears, rallies toward $44–$50 will meet sellers who bought at $50.